ProCE Banner Activity

CDK4/6 Inhibitors in HR+/HER2- Breast Cancer: Addressing Barriers to Their Optimal Use

Slideset

To access the downloadable PowerPoint slide set on CDK4/6 inhibitors in HR+/HER2- breast cancer, please click the download button.

Released: April 22, 2022

Expiration: April 21, 2023

No longer available for credit.

Share

Acknowledgement

This activity is supported by an educational grant from Lilly.

Supporters

Lilly

Additional Information

Program Medium

This program has been made available online.